{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:08:58Z","timestamp":1794107338964,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007732","name":"American Macular Degeneration Foundation","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100007732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41433-021-01780-y","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T11:02:51Z","timestamp":1641898971000},"page":"312-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Dyslipidemia in age-related macular degeneration"],"prefix":"10.1038","volume":"36","author":[{"given":"Jonathan B.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar A.","family":"Halawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeba","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2046-3996","authenticated-orcid":false,"given":"Joan W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8622-6478","authenticated-orcid":false,"given":"Demetrios G.","family":"Vavvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"1780_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CMG, Klein R, Cheng C-Y, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u201316.","journal-title":"Lancet Glob Health"},{"key":"1780_CR2","doi-asserted-by":"publisher","first-page":"E696","DOI":"10.1073\/pnas.1718059115","volume":"115","author":"DG Vavvas","year":"2018","unstructured":"Vavvas DG, Small KW, Awh CC, Zanke BW, Tibshirani RJ, Kustra R. CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation. Proc Natl Acad Sci USA. 2018;115:E696\u2013704.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1780_CR3","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.ophtha.2013.01.021","volume":"120","author":"EY Chew","year":"2013","unstructured":"Chew EY, Clemons TE, Agr\u00f3n E, Sperduto RD, Sangiovanni JP, Kurinij N, et al. Long-term effects of vitamins C and E, \u03b2-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology. 2013;120:1604\u201311.e4.","journal-title":"Ophthalmology."},{"key":"1780_CR4","doi-asserted-by":"publisher","first-page":"e10329","DOI":"10.1371\/journal.pone.0010329","volume":"5","author":"L Wang","year":"2010","unstructured":"Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, Mobley JA, et al. Abundant lipid and protein components of drusen. PLoS ONE. 2010;5:e10329.","journal-title":"PLoS ONE"},{"key":"1780_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1136\/bjophthalmol-2011-300344","volume":"95","author":"CA Curcio","year":"2011","unstructured":"Curcio CA, Johnson M, Rudolf M, Huang J-D. The oil spill in ageing Bruch membrane. Br J Ophthalmol. 2011;95:1638\u201345.","journal-title":"Br J Ophthalmol"},{"key":"1780_CR6","doi-asserted-by":"publisher","first-page":"AMD160","DOI":"10.1167\/iovs.18-24882","volume":"59","author":"CA Curcio","year":"2018","unstructured":"Curcio CA. Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies. Investig Ophthalmol Vis Sci. 2018;59:AMD160\u201381.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1780_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1076\/opge.23.4.209.13883","volume":"23","author":"S Schmidt","year":"2002","unstructured":"Schmidt S, Klaver C, Saunders A, Postel E, De La Paz M, Agarwal A, et al. A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet. 2002;23:209\u201323.","journal-title":"Ophthalmic Genet"},{"key":"1780_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1086\/301901","volume":"63","author":"CC Klaver","year":"1998","unstructured":"Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998;63:200\u20136.","journal-title":"Am J Hum Genet"},{"key":"1780_CR9","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1073\/pnas.0912019107","volume":"107","author":"BM Neale","year":"2010","unstructured":"Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA. 2010;107:7395\u2013400.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1780_CR10","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1073\/pnas.0912702107","volume":"107","author":"W Chen","year":"2010","unstructured":"Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA. 2010;107:7401\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1780_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JNC, Grassmann F, Sengupta S, Bragg-Gresham JL, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134\u201343.","journal-title":"Nat Genet"},{"key":"1780_CR12","doi-asserted-by":"crossref","unstructured":"Wang Y, Wang M, Zhang X, Zhang Q, Nie J, Zhang M, et al. The association between the lipids levels in blood and risk of age-related macular degeneration. Nutrients. 2016;8:663.","DOI":"10.3390\/nu8100663"},{"key":"1780_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ophtha.2018.09.045","volume":"126","author":"JM Colijn","year":"2019","unstructured":"Colijn JM, den Hollander AI, Demirkan A, Cougnard-Gr\u00e9goire A, Verzijden T, Kersten E, et al. Increased high-density lipoprotein levels associated with age-related macular degeneration: evidence from the EYE-RISK and European Eye Epidemiology Consortia. Ophthalmology. 2019;126:393\u2013406.","journal-title":"Ophthalmology."},{"key":"1780_CR14","doi-asserted-by":"publisher","first-page":"e0132565","DOI":"10.1371\/journal.pone.0132565","volume":"10","author":"JLY Yip","year":"2015","unstructured":"Yip JLY, Khawaja AP, Chan MPY, Broadway DC, Peto T, Tufail A, et al. Cross sectional and longitudinal associations between cardiovascular risk factors and age related macular degeneration in the EPIC-Norfolk Eye Study. PLoS ONE. 2015;10:e0132565.","journal-title":"PLoS ONE"},{"key":"1780_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ophtha.2017.03.042","volume":"124","author":"S Burgess","year":"2017","unstructured":"Burgess S, Davey, Smith G. Mendelian randomization implicates high-density lipoprotein cholesterol-associated mechanisms in etiology of age-related macular degeneration. Ophthalmology. 2017;124:1165\u201374.","journal-title":"Ophthalmology."},{"key":"1780_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/archopht.117.3.329","volume":"117","author":"CA Curcio","year":"1999","unstructured":"Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol. 1999;117:329\u201339.","journal-title":"Arch Ophthalmol"},{"key":"1780_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1167\/iovs.06-0443","volume":"48","author":"S Sarks","year":"2007","unstructured":"Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Investig Ophthalmol Vis Sci. 2007;48:968\u201377.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1780_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/00006982-199414020-00006","volume":"14","author":"NM Bressler","year":"1994","unstructured":"Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina. 1994;14:130\u201342.","journal-title":"Retina."},{"key":"1780_CR19","doi-asserted-by":"publisher","first-page":"AMD182","DOI":"10.1167\/iovs.18-24883","volume":"59","author":"CA Curcio","year":"2018","unstructured":"Curcio CA. Antecedents of soft drusen, the specific deposits of age-related macular degeneration, in the biology of human macula. Investig Ophthalmol Vis Sci. 2018;59:AMD182\u201394.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1780_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1167\/iovs.62.1.33","volume":"62","author":"L Chen","year":"2021","unstructured":"Chen L, Messinger JD, Kar D, Duncan JL, Curcio CA. Biometrics, impact, and significance of basal linear deposit and subretinal drusenoid deposit in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2021;62:33.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1780_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844\u201351.","journal-title":"Ophthalmology."},{"key":"1780_CR22","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1001\/archopht.123.11.1570","volume":"123","author":"FL Ferris","year":"2005","unstructured":"Ferris FL, Davis MD, Clemons TE, Lee L-Y, Chew EY, Lindblad AS, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol. 2005;123:1570\u20134.","journal-title":"Arch Ophthalmol"},{"key":"1780_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ajo.2014.06.021","volume":"158","author":"NA Nathoo","year":"2014","unstructured":"Nathoo NA, Or C, Young M, Chui L, Fallah N, Kirker AW, et al. Optical coherence tomography-based measurement of drusen load predicts development of advanced age-related macular degeneration. Am J Ophthalmol. 2014;158:757\u201361.e1.","journal-title":"Am J Ophthalmol"},{"key":"1780_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ophtha.2015.09.016","volume":"123","author":"FA Folgar","year":"2016","unstructured":"Folgar FA, Yuan EL, Sevilla MB, Chiu SJ, Farsiu S, Chew EY, et al. Drusen volume and retinal pigment epithelium abnormal thinning volume predict 2-year progression of age-related macular degeneration. Ophthalmology. 2016;123:39\u201350.e1.","journal-title":"Ophthalmology."},{"key":"1780_CR25","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.1073\/pnas.222551899","volume":"99","author":"JW Crabb","year":"2002","unstructured":"Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1780_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.preteyeres.2018.12.003","volume":"70","author":"AA Bergen","year":"2019","unstructured":"Bergen AA, Arya S, Koster C, Pilgrim MG, Wiatrek-Moumoulidis D, van der Spek PJ, et al. On the origin of proteins in human drusen: the meet, greet and stick hypothesis. Prog Retin Eye Res. 2019;70:55\u201384.","journal-title":"Prog Retin Eye Res"},{"key":"1780_CR27","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1111\/aos.14280","volume":"98","author":"B Fern\u00e1ndez-Vega","year":"2020","unstructured":"Fern\u00e1ndez-Vega B, Garc\u00eda M, Olivares L, \u00c1lvarez L, Gonz\u00e1lez-Fern\u00e1ndez A, Artime E, et al. The association study of lipid metabolism gene polymorphisms with AMD identifies a protective role for APOE-E2 allele in the wet form in a Northern Spanish population. Acta Ophthalmol. 2020;98:e282\u201391.","journal-title":"Acta Ophthalmol"},{"key":"1780_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s10038-020-0750-x","volume":"65","author":"X Han","year":"2020","unstructured":"Han X, Gharahkhani P, Mitchell P, Liew G, Hewitt AW, MacGregor S. Genome-wide meta-analysis identifies novel loci associated with age-related macular degeneration. J Hum Genet. 2020;65:657\u201365.","journal-title":"J Hum Genet"},{"key":"1780_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ophtha.2017.08.008","volume":"125","author":"I La\u00edns","year":"2018","unstructured":"La\u00edns I, Kelly RS, Miller JB, Silva R, Vavvas DG, Kim IK, et al. Human plasma metabolomics study across all stages of age-related macular degeneration identifies potential lipid biomarkers. Ophthalmology. 2018;125:245\u201354.","journal-title":"Ophthalmology."},{"key":"1780_CR30","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.ophtha.2020.06.020","volume":"127","author":"\u0130E Acar","year":"2020","unstructured":"Acar \u0130E, Lores-Motta L, Colijn JM, Meester-Smoor MA, Verzijden T, Cougnard-Gregoire A, et al. Integrating metabolomics, genomics, and disease pathways in age-related macular degeneration: the EYE-RISK consortium. Ophthalmology. 2020;127:1693\u2013709.","journal-title":"Ophthalmology."},{"key":"1780_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/0002-9394(63)92428-0","volume":"55","author":"MJ Albrink","year":"1963","unstructured":"Albrink MJ, Fasanella RM. Serum lipids in patients with senile macular degeneration. Am J Ophthalmol. 1963;55:709\u201313.","journal-title":"Am J Ophthalmol"},{"key":"1780_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000309370","volume":"188","author":"JS Vidaurri","year":"1984","unstructured":"Vidaurri JS, Pe\u2019er J, Halfon ST, Halperin G, Zauberman H. Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica. 1984;188:243\u20137.","journal-title":"Ophthalmologica."},{"key":"1780_CR33","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/oxfordjournals.aje.a115023","volume":"128","author":"J Goldberg","year":"1988","unstructured":"Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988;128:700\u201310.","journal-title":"Am J Epidemiol"},{"key":"1780_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/oxfordjournals.aje.a113624","volume":"118","author":"FL Ferris","year":"1983","unstructured":"Ferris FL. Senile macular degeneration: review of epidemiologic features. Am J Epidemiol. 1983;118:132\u201351.","journal-title":"Am J Epidemiol"},{"key":"1780_CR35","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/archopht.1992.01080240041025","volume":"110","author":"Anon. Risk factors for neovascular age-related macular degeneration.","year":"1992","unstructured":"Anon. Risk factors for neovascular age-related macular degeneration. The eye disease case-control study group. Arch Ophthalmol. 1992;110:1701\u20138.","journal-title":"Arch Ophthalmol"},{"key":"1780_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0161-6420(93)31634-9","volume":"100","author":"R Klein","year":"1993","unstructured":"Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1993;100:406\u201314.","journal-title":"Ophthalmology."},{"key":"1780_CR37","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0161-6420(03)00599-2","volume":"110","author":"R Klein","year":"2003","unstructured":"Klein R, Klein BEK, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 2003;110:1273\u201380.","journal-title":"Ophthalmology."},{"key":"1780_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/archopht.118.3.351","volume":"118","author":"L Hyman","year":"2000","unstructured":"Hyman L, Schachat AP, He Q, Leske MC. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-related macular degeneration risk factors study group. Arch Ophthalmol. 2000;118:351\u20138.","journal-title":"Arch Ophthalmol"},{"key":"1780_CR39","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ajo.2003.09.015","volume":"137","author":"R van Leeuwen","year":"2004","unstructured":"van Leeuwen R, Klaver CCW, Vingerling JR, Hofman A, van Duijn CM, Stricker BHC, et al. Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol. 2004;137:750\u20132.","journal-title":"Am J Ophthalmol"},{"key":"1780_CR40","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.ophtha.2003.11.010","volume":"111","author":"SC Tomany","year":"2004","unstructured":"Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111:1280\u20137.","journal-title":"Ophthalmology."},{"key":"1780_CR41","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/bjo.2006.093856","volume":"90","author":"N Dashti","year":"2006","unstructured":"Dashti N, McGwin G, Owsley C, Curcio CA. Plasma apolipoproteins and risk for age related maculopathy. Br J Ophthalmol. 2006;90:1028\u201333.","journal-title":"Br J Ophthalmol"},{"key":"1780_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ajo.2014.05.027","volume":"158","author":"R Klein","year":"2014","unstructured":"Klein R, Myers CE, Buitendijk GHS, Rochtchina E, Gao X, de Jong PTVM, et al. Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortium. Am J Ophthalmol. 2014;158:513\u201324.e3.","journal-title":"Am J Ophthalmol"},{"key":"1780_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-10-31","volume":"10","author":"U Chakravarthy","year":"2010","unstructured":"Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol. 2010;10:31.","journal-title":"BMC Ophthalmol"},{"key":"1780_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18487-4","volume":"8","author":"M Sasaki","year":"2018","unstructured":"Sasaki M, Harada S, Kawasaki Y, Watanabe M, Ito H, Tanaka H, et al. Gender-specific association of early age-related macular degeneration with systemic and genetic factors in a Japanese population. Sci Rep. 2018;8:785.","journal-title":"Sci Rep"},{"key":"1780_CR45","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/ije\/dyx189","volume":"46","author":"Q Fan","year":"2017","unstructured":"Fan Q, Maranville JC, Fritsche L, Sim X, Cheung CMG, Chen LJ, et al. HDL-cholesterol levels and risk of age-related macular degeneration: a multiethnic genetic study using Mendelian randomization. Int J Epidemiol. 2017;46:1891\u2013902.","journal-title":"Int J Epidemiol"},{"key":"1780_CR46","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/ije\/dyaa178","volume":"50","author":"X Han","year":"2021","unstructured":"Han X, Ong J-S, Hewitt AW, Gharahkhani P, MacGregor S. The effects of eight serum lipid biomarkers on age-related macular degeneration risk: a Mendelian randomization study. Int J Epidemiol. 2021;50:325\u201336.","journal-title":"Int J Epidemiol"},{"key":"1780_CR47","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.12659\/MSM.915493","volume":"25","author":"L L\u00fcdtke","year":"2019","unstructured":"L\u00fcdtke L, J\u00fcrgens C, Ittermann T, V\u00f6lzke H, Tost F. Age-related macular degeneration and associated risk factors in the population-based study of health in pomerania (SHIP-Trend). Med Sci Monit. 2019;25:6383\u201390.","journal-title":"Med Sci Monit"},{"key":"1780_CR48","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1167\/iovs.19-27325","volume":"60","author":"F Mao","year":"2019","unstructured":"Mao F, Yang X, Yang K, Cao X, Cao K, Hao J, et al. Six-year incidence and risk factors for age-related macular degeneration in a rural Chinese population: the Handan Eye study. Investig Ophthalmol Vis Sci. 2019;60:4966\u201371.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1780_CR49","doi-asserted-by":"publisher","first-page":"13601","DOI":"10.1074\/jbc.RA119.012305","volume":"295","author":"UL Kelly","year":"2020","unstructured":"Kelly UL, Grigsby D, Cady MA, Landowski M, Skiba NP, Liu J, et al. High-density lipoproteins are a potential therapeutic target for age-related macular degeneration. J Biol Chem. 2020;295:13601\u201316.","journal-title":"J Biol Chem"},{"key":"1780_CR50","doi-asserted-by":"crossref","unstructured":"Gehlbach P, Li T, Hatef E. Statins for age-related macular degeneration. Cochrane Database Syst Rev. 2016;2016:CD006927.","DOI":"10.1002\/14651858.CD006927.pub5"},{"key":"1780_CR51","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/bmj.326.7383.255","volume":"326","author":"R van Leeuwen","year":"2003","unstructured":"van Leeuwen R, Vingerling JR, Hofman A, de Jong PTVM, Stricker BHC. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ. 2003;326:255\u20136.","journal-title":"BMJ"},{"key":"1780_CR52","first-page":"615","volume":"137","author":"HL Wilson","year":"2004","unstructured":"Wilson HL, Schwartz DM, Bhatt HRF, McCulloch CE, Duncan JL. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am J Ophthalmol. 2004;137:615\u201324.","journal-title":"Am J Ophthalmol"},{"key":"1780_CR53","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/IAE.0b013e318276e0cf","volume":"33","author":"BL VanderBeek","year":"2013","unstructured":"VanderBeek BL, Zacks DN, Talwar N, Nan B, Stein JD. Role of statins in the development and progression of age-related macular degeneration. Retina. 2013;33:414\u201322.","journal-title":"Retina."},{"key":"1780_CR54","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1124\/dmd.118.083345","volume":"46","author":"N Mast","year":"2018","unstructured":"Mast N, Bederman IR, Pikuleva IA. Retinal Cholesterol Content Is Reduced In Simvastatin-treated Mice Due To Inhibited Local Biosynthesis Albeit Increased Uptake Of Serum Cholesterol. Drug Metab Dispos. 2018;46:1528\u201337.","journal-title":"Drug Metab Dispos"},{"key":"1780_CR55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ebiom.2016.01.033","volume":"5","author":"DG Vavvas","year":"2016","unstructured":"Vavvas DG, Daniels AB, Kapsala ZG, Goldfarb JW, Ganotakis E, Loewenstein JI, et al. Regression of some high-risk features of age-related macular degeneration (AMD) in patients receiving intensive statin treatment. EBioMedicine. 2016;5:198\u2013203.","journal-title":"EBioMedicine."},{"key":"1780_CR56","doi-asserted-by":"publisher","first-page":"e83759","DOI":"10.1371\/journal.pone.0083759","volume":"8","author":"RH Guymer","year":"2013","unstructured":"Guymer RH, Baird PN, Varsamidis M, Busija L, Dimitrov PN, Aung KZ, et al. Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration. PLoS ONE. 2013;8:e83759.","journal-title":"PLoS ONE"},{"key":"1780_CR57","doi-asserted-by":"publisher","first-page":"E301","DOI":"10.3390\/ijerph18010301","volume":"18","author":"K Wang","year":"2021","unstructured":"Wang K, Hsieh M-J, Chien H-W, Lee C-Y, Yeh C-B, Huang J-Y, et al. Medical compliance of fibrate and the decreased risk of age-related macular degeneration in dyslipidemia-related diseases: a population-based cohort study. Int J Environ Res Public Health. 2021;18:E301.","journal-title":"Int J Environ Res Public Health"},{"key":"1780_CR58","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1001\/jama.291.9.1071","volume":"291","author":"SE Nissen","year":"2004","unstructured":"Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004;291:1071\u201380.","journal-title":"JAMA."},{"key":"1780_CR59","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495\u2013504.","journal-title":"N Engl J Med"},{"key":"1780_CR60","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1161\/ATVBAHA.120.314609","volume":"40","author":"FM Sacks","year":"2020","unstructured":"Sacks FM, Liang L, Furtado JD, Cai T, Davidson WS, He Z, et al. Protein-defined subspecies of HDLs (High-density lipoproteins) and differential risk of coronary heart disease in 4 prospective studies. Arterioscler Thromb Vasc Biol. 2020;40:2714\u201327.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1780_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1194\/jlr.M064469","volume":"57","author":"JB Lin","year":"2016","unstructured":"Lin JB, Mast N, Bederman IR, Li Y, Brunengraber H, Bj\u00f6rkhem I, et al. Cholesterol in mouse retina originates primarily from in situ de novo biosynthesis. J Lipid Res. 2016;57:258\u201364.","journal-title":"J Lipid Res"},{"key":"1780_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","volume":"17","author":"A Sene","year":"2013","unstructured":"Sene A, Khan AA, Cox D, Nakamura REI, Santeford A, Kim BM, et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 2013;17:549\u201361.","journal-title":"Cell Metab"},{"key":"1780_CR63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","volume":"24","author":"R van der Kant","year":"2019","unstructured":"van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y, et al. Cholesterol metabolism is a druggable axis that independently regulates tau and amyloid-\u03b2 in iPSC-derived Alzheimer\u2019s disease neurons. Cell Stem Cell. 2019;24:363\u201375.e9.","journal-title":"Cell Stem Cell"},{"key":"1780_CR64","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.3390\/molecules26102838","volume":"26","author":"M Kosowski","year":"2021","unstructured":"Kosowski M, Smolarczyk-Kosowska J, Hachu\u0142a M, Malig\u0142\u00f3wka M, Basiak M, Machnik G, et al. The effects of statins on neurotransmission and their neuroprotective role in neurological and psychiatric disorders. Molecules. 2021;26:2838.","journal-title":"Molecules."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01780-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01780-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01780-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T16:06:20Z","timestamp":1667059580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01780-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1780"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01780-y","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"4 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}